SS-31 vs Carnosine
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Elamipretide, Bendavia
SS-31 (sequence D-Arg-Dmt-Lys-Phe-NH2), known generically as elamipretide and sold as FORZINITY, is a synthetic tetrapeptide that homes in on the energy-producing machinery inside your cells. It works by binding cardiolipin, a fat unique to the inner mitochondrial membrane, to help mitochondria run cleaner and make more ATP with less oxidative damage. This is the rare research peptide with a real regulatory finish line: the FDA granted it accelerated approval in September 2025 for Barth syndrome, though it has failed several other major trials.
Also: L-Carnosine, beta-Alanyl-L-histidine
Carnosine is a dipeptide (beta-alanine plus histidine) your body makes and stores in muscle and brain, and it is also sold as an oral supplement and used in skincare. Its anti-aging reputation rests on fighting glycation, the sugar damage that stiffens collagen, plus antioxidant and pH-buffering roles. It is a dietary supplement and cosmetic ingredient, not an FDA-approved drug, and the human evidence is real but small and patchy.
Key Comparison Insights
- SS-31 is FDA approved, while Carnosine remains in research stages.
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- SS-31 has stronger research evidence (FDA Approved) compared to Carnosine (Human Trials).
Detailed Comparison
| Attribute | SS-31 | Carnosine |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | SS-31 is a cell-permeable, mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane and binds tightly to cardiolipin. Cardiolipin is essential for keeping the membrane's folded cristae structure intact and for organizing the proteins of the electron transport chain that generate ATP. By stabilizing cardiolipin, SS-31 helps preserve cristae shape, reduces the electron leakage that produces reactive oxygen species, and supports more efficient ATP production. Studies also suggest it modulates the membrane's surface electrostatics and can limit opening of the mitochondrial permeability transition pore, a trigger for cell death, though the full mechanistic picture is still being worked out. | In muscle, carnosine buffers acid during hard exercise. Beyond that, it mops up reactive carbonyls like methylglyoxal, chelates metals and acts as an antioxidant, which is why it is called an anti-glycation agent: it may reduce the formation of advanced glycation end-products (AGEs) that cross-link collagen and make skin and blood vessels stiffer. The catch with oral carnosine is that enzymes called carnosinases break it down fast, with a blood half-life under five minutes, so much of an oral dose ends up as beta-alanine and histidine. That is why sports scientists raise muscle carnosine with beta-alanine instead. Topically, the anti-glycation effect has been shown on skin samples in the lab. |
| Common Dosing | 40 mg daily Once daily | 500 mg to 1 g per day orally Once or twice daily (split doses because it breaks down quickly) |
| Administration | Subcutaneous injection or IV infusion | Oral capsules or powder; topical creams |
| Typical Duration | Variable by condition | Oral trials usually ran 8 to 12 weeks; skin study ran 3 months |
| Best Time to Take | Morning | Split between morning and evening |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Unlike most peptides in this space, SS-31 has been through extensive human trials, with a mixed but consequential record. In TAZPOWER, a randomized placebo-controlled crossover study in Barth syndrome, elamipretide improved skeletal muscle strength and cardiac stroke volume, and the long open-label extension showed sustained benefit, which ultimately supported FDA accelerated approval in September 2025 as the first treatment for that ultra-rare disease. It has also failed prominently: the Phase 3 MMPOWER-3 trial in primary mitochondrial myopathy missed its primary endpoints on the six-minute walk test, the ReCLAIM trial in dry age-related macular degeneration did not hit its primary endpoints, and a heart-failure trial (PROGRESS-HF) also missed its primary endpoint. Across these studies the drug was generally well tolerated, with mostly mild effects such as injection-site reactions, headache and nausea. The accurate summary is that SS-31 is a validated mitochondrial-targeting peptide with one approved indication and a string of negative trials elsewhere, so its benefit appears to depend heavily on the specific disease. | Oral: a 2023 narrative review in Nutrients (Cesak and colleagues) found small but positive trials for blood sugar control (for example, 2 g a day for 12 weeks lowered fasting insulin and insulin resistance in a 30-person pilot), mixed or inconclusive results for heart disease, autism and schizophrenia, and cognitive benefits mostly from carnosine combined with anserine, which muddies attribution. Typical trial doses were 500 mg to 2 g a day. The best-supported clinical use is actually zinc-carnosine for mouth sores and stomach lining, a different compound. Skin: a 2012 oral study of 42 people reported better skin parameters and fewer fine lines over three months, but the lead author's company sells the tested patented formula, and the paper is more advocacy than independent trial. Topical: a 2018 study found a 0.2 percent carnosine cream cut glycation markers in human skin samples, but the authors work for the company that makes the cream and the tissue came from one donor. Honest read: safe, cheap, plausible, with small human trials and plenty of commercial interest behind the skin claims. |
Frequently Asked Questions: SS-31 vs Carnosine
What is the difference between SS-31 and Carnosine?
SS-31 is a anti-aging peptide that ss-31 (sequence d-arg-dmt-lys-phe-nh2), known generically as elamipretide and sold as forzinity, is a synthetic tetrapeptide that homes in on the energy-producing machinery inside your cells. it works by binding cardiolipin, a fat unique to the inner mitochondrial membrane, to help mitochondria run cleaner and make more atp with less oxidative damage. this is the rare research peptide with a real regulatory finish line: the fda granted it accelerated approval in september 2025 for barth syndrome, though it has failed several other major trials. Carnosine is a anti-aging peptide that carnosine is a dipeptide (beta-alanine plus histidine) your body makes and stores in muscle and brain, and it is also sold as an oral supplement and used in skincare. its anti-aging reputation rests on fighting glycation, the sugar damage that stiffens collagen, plus antioxidant and ph-buffering roles. it is a dietary supplement and cosmetic ingredient, not an fda-approved drug, and the human evidence is real but small and patchy. The main differences lie in their mechanisms of action and clinical applications.
Which is better, SS-31 or Carnosine?
Neither is universally "better" - the choice depends on your specific goals. SS-31 is typically used for anti-aging purposes, while Carnosine is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can SS-31 and Carnosine be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using SS-31 and Carnosine together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.